Reconstruction of a swine SLA-I protein complex and determination of binding nonameric peptides derived from the foot-and-mouth disease virus

Veterinary Immunology and Immunopathology

Volumn 113, Issue 3-4, 2006, Pages 328-338

  Gao, Feng Shan ^a,b   Fang, Qin Mei ^a   Li, Yun Gang ^a   Li, Xin Sheng ^a   Hao, Hui Fang ^a   Xia, Chun ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY   (China)

Author keywords

2m; Circular dichroism spectrum; Foot and mouth disease virus; SLA I; Swine; T cell epitope

Indexed keywords

2 DIETHYLAMINOETHANOL; ARGINYLARGINYLGLUTAMINYLHISTIDYLTHREONYLASPARTYLVALYLSERYLPHENYLALANINE; ARGINYLTHREONYLLEUCYLPROLYLTHREONYLSERYLPHENYLALANYLASPARAGINYLTYROSINE; ESCHERICHIA COLI PROTEIN; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; PEPTIDE; PROTEIN; SEPHAROSE; SWINE LEUKOCYTE ANTIGEN 1; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; FOOT AND MOUTH DISEASE VIRUS; GENE; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; SWINE;

ANIMALS; BETA 2-MICROGLOBULIN; BLOTTING, WESTERN; CAPSID PROTEINS; CIRCULAR DICHROISM; DNA, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES, T-LYMPHOCYTE; FOOT-AND-MOUTH DISEASE VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SWINE; SWINE, MINIATURE;

FOOT-AND-MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE VIRUS - TYPE O; SUS SCROFA;

EID: 33747826322     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.06.002     Document Type: Article

References (55)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
2. Ando A., Kawata H., Shigenari A., Anzai T., Ota M., Katsuyama Y., Sada M., Goto R., Takeshima S.N., Aida Y., Iwanaga T., Fujimura N., Suzuki Y., Gojobori T., and Inoko H. Genetic polymorphism of the swine major histocompatibility complex (SLA) class I genes, SLA-1, -2 and -3. Immunogenetics 55 (2003) 583-593
3. Barteling S.J., and Woortmeyer R. Multiple variants in foot-and-mouse disease virus (FMDV) populations: the Achilles heel for peptide and rec. DNA vaccines?. Dev. Biol. Stand. 66 (1987) 511-521
4. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., and Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-33
5. Bjorkman P.J., and Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59 (1990) 253-288
6. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., and Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329 (1987) 506-512
7. Blanco E., Garcia-Briones M., Sanz-Parra A., Gomes P., De Oliveira E., Valero M.L., Andreu D., Ley V., and Sobrino F. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J. Virol. 75 (2001) 3164-3174
8. Bonner P.L., Lill J.R., Hill S., Creaser C.S., and Rees R.C. Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells. J. Immunol. Meth. 262 (2002) 5-19
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
10. Brown F. New approaches to vaccination against foot-and-mouth disease. Vaccine 10 (1992) 1022-1026
11. Chardon P., Renard C., and Vaiman M. The major histocompatibility complex in swine. Immunol. Rev. 167 (1999) 179-192
12. Chen Y.H., Yang J.T., and Martinez H.M. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11 (1972) 4120-4131
13. Coles R.M., Jones C.M., Brooks A.G., Cameron P.U., Heath W.R., and Carbone F.R. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes. Eur. J. Immunol. 33 (2003) 1557-1567
14. Dressel R., Walter L., and Gunther E. Genomic and functional aspects of the rat MHC, the RT1 complex. Immunol. Rev. 184 (2001) 82-95
15. Ennis P.D., Jackson A.P., and Parham P. Molecular cloning of bovine class I MHC cDNA. J. Immunol. 141 (1988) 642-651
16. Fujiwara A., Kiryu I., Dijkstra J.M., Yoshiura Y., Nishida-Umehara C., and Ototake M. Chromosome mapping of MHC class I in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 14 (2003) 171-175
17. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., and Jakobsen B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387 (1997) 630-634
18. Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., and Wiley D.C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384 (1996) 134-141
19. Glass E.J., Oliver R.A., Collen T., Doel T.R., Dimarchi R., and Spooner R.L. MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology 74 (1991) 594-599
20. Gleimer M., and Parham P. Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity 19 (2003) 469-477
21. Godeau F., Luescher I.F., Ojcius D.M., Saucier C., Mottez E., Cabanie L., and Kourilsky P. Purification and ligand binding of a soluble class I major histocompatibility complex molecule consisting of the first three domains of H-2Kd fused to beta 2-microglobulin expressed in the baculovirus-insect cell system. J. Biol. Chem. 267 (1992) 24223-24229
22. Hauptmann G., and Bahram S. Genetics of the central MHC. Curr. Opin. Immunol. 16 (2004) 668-672
23. Kapust R.B., and Waugh D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 8 (1999) 1668-1674
24. Kaufman J., Milne S., Gobel T.W., Walker B.A., Jacob J.P., Auffray C., Zoorob R., and Beck S. The chicken B locus is a minimal essential major histocompatibility complex. Nature 401 (1999) 923-925
25. Kievits F., Ivanyi P., Krimpenfort P., Berns A., and Ploegh H.L. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 329 (1987) 447-449
26. *2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98 (2001) 1872-1881
27. Lokshin A.E., Kalinski P., Sassi R.R., Mailliard R.B., Muller-Berghaus J., Storkus W.J., Peng X., Marrangoni A.M., Edwards R.P., and Gorelik E. Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. Int. Immunol. 14 (2002) 1027-1037
28. Madden D.R., Garboczi D.N., and Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75 (1993) 693-708
29. Martins C.L., Lawman M.J., Scholl T., Mebus C.A., and Lunney J.K. African swine fever virus specific porcine cytotoxic T cell activity. Arch. Virol. 129 (1993) 211-225
30. Meijers R., Lai C.C., Yang Y., Liu J.H., Zhong W., Wang J.H., and Reinherz E.L. Crystal structures of murine MHC class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. J. Mol. Biol. 345 (2005) 1099-1110
31. Milland J., Loveland B.E., and McKenzie I.F. Isolation of a clone for pig beta 2-microglobulin cDNA. Immunogenetics 38 (1993) 464
32. NEB. pMAL™ Protein Fusion and Purification System Instruction Manual, Version 5.01 (2006), New England BioLabs Inc.
33. Oleksiewicz M.B., Kristensen B., Ladekjaer-Mikkelsen A.S., and Nielsen J. Development of a rapid in vitro protein refolding assay which discriminates between peptide-bound and peptide-free forms of recombinant porcine major histocompatibility class I complex (SLA-I). Vet. Immunol. Immunopathol. 86 (2002) 55-77
34. Pfaff E., Mussgay M., Bohm H.O., Schulz G.E., and Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1 (1982) 869-874
35. Rodriguez A., Ley V., Ortuno E., Ezquerra A., Saalmuller A., Sobrino F., and Saiz J.C. A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J. Gen. Virol. 77 Pt. 9 (1996) 2089-2096
36. Rodriguez L.L., Barrera J., Kramer E., Lubroth J., Brown F., and Golde W.T. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21 (2003) 3751-3756
37. Sanz-Parra A., Sobrino F., and Ley V. Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J. Gen. Virol. 79 Pt. 3 (1998) 433-436
38. Saper M.A., Bjorkman P.J., and Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J. Mol. Biol. 219 (1991) 277-319
39. Schutze-Redelmeier M.P., Gournier H., Garcia-Pons F., Moussa M., Joliot A.H., Volovitch M., Prochiantz A., and Lemonnier F.A. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J. Immunol. 157 (1996) 650-655
40. Shawar S.M., Cook R.G., Rodgers J.R., and Rich R.R. Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. J. Exp. Med. 171 (1990) 897-912
41. Stewart C.A., Horton R., Allcock R.J., Ashurst J.L., Atrazhev A.M., Coggill P., Dunham I., Forbes S., Halls K., Howson J.M., Humphray S.J., Hunt S., Mungall A.J., Osoegawa K., Palmer S., Roberts A.N., Rogers J., Sims S., Wang Y., Wilming L.G., Elliott J.F., de Jong P.J., Sawcer S., Todd J.A., Trowsdale J., and Beck S. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14 (2004) 1176-1187
42. Sugawara S., Abo T., and Kumagai K. A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J. Immunol. Meth. 100 (1987) 83-90
43. Sullivan J.A., Oettinger H.F., Sachs D.H., and Edge A.S. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J. Immunol. 159 (1997) 2318-2326
44. The MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 401 (1999) 921-923
45. Trowsdale J., and Campbell R.D. Complexity in the major histocompatibility complex. Eur. J. Immunogenet. 19 (1992) 45-55
46. Velten F.W., Renard C., Rogel-Gaillard C., Vaiman M., and Chardon P. Spatial arrangement of pig MHC class I sequences. Immunogenetics 49 (1999) 919-930
47. Whelan J.A., Dunbar P.R., Price D.A., Purbhoo M.A., Lechner F., Ogg G.S., Griffiths G., Phillips R.E., Cerundolo V., and Sewell A.K. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163 (1999) 4342-4348
48. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4 (2003) 913-919
49. Xia C.D.W., Wen-Xue W., Jian-Qing W., Li W., Tian-Yao Y., Qin W., and Yi-Bao N. Cloning and expression of interferon-alpha/gamma from a domestic porcine breed and its effect on classical swine fever virus. Vet. Immunol. Immunopathol. 104 (2005) 81-89
50. Xia C., Hu T., Yang T., Wang L., Xu G., and Lin C. cDNA cloning, genomic structure and expression analysis of the goose (Anser cygnoides) MHC class I gene. Vet. Immunol. Immunopathol. 107 (2005) 291-302
51. Yan, R.Q., Li, X.S., Yang, T.Y., Xia, C., 2005. Structures and homology modeling of chicken major histocompatibility complex protein class I (BF2 and beta2m). Mol. Immunol.
52. Yano A., Onozuka A., Asahi-Ozaki Y., Imai S., Hanada N., Miwa Y., and Nisizawa T. An ingenious design for peptide vaccines. Vaccine 23 (2005) 2322-2326
53. Zamorano P.I., Wigdorovitz A., Perez Filgueira D.M., Escribano J.M., Sadir A.M., and Borca M.V. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Vaccine 16 (1998) 558-563
54. Zhang X., Liu Z., Zhao Q., Chang H., and Xie Q. Sequencing and analysis for the full-length genome RNA of foot-and-mouth disease virus China/99. Sci. China C: Life Sci. 47 (2004) 74-81
55. Zhao B., Mathura V.S., Rajaseger G., Moochhala S., Sakharkar M.K., and Kangueane P. A novel MHCp binding prediction model. Hum. Immunol. 64 (2003) 1123-1143